Martin Ekwealor Pharmaceuticals Inc

FDA Filings

This page includes the latest FDA filings for Martin Ekwealor Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
NDC 58607-918 MARTIN EKWEALOR PHARMACEUTICALS, INC.	Lidocaine	2017-03-04
Lidocaine MARTIN EKWEALOR PHARMACEUTICALS, INC.	Prescription Medication	2017-03-04
FERROUS SULFATE MARTIN EKWEALOR PHARMACEUTICALS, INC., MARTIN EKWEALOR PHARMACEUTICALS, INC	Otc Medication	2014-10-02
NDC 58607-113 MARTIN EKWEALOR PHARMACEUTICALS, INC.	FERROUS SULFATE	2014-09-01
Myferon 150 MARTIN EKWEALOR PHARMACEUTICALS, INC.	Otc Medication	2014-03-07
Myferon 150 Forte MARTIN EKWEALOR PHARMACEUTICALS, INC.	Prescription Medication	2014-03-06
Polyethylene Glycol 3350 NF MARTIN EKWEALOR PHARMACEUTICALS, INC.	Prescription Medication	2014-02-04
MYNEPHROCAPS MARTIN EKWEALOR PHARMACEUTICALS, INC.	Prescription Medication	2013-12-27
NDC 58607-700 MARTIN EKWEALOR PHARMACEUTICALS, INC.	Polyethylene Glycol 3350 NF	2013-12-16
NDC 58607-186 MARTIN EKWEALOR PHARMACEUTICALS, INC.	MYNEPHROCAPS	2013-12-16
NDC 58607-112 MARTIN EKWEALOR PHARMACEUTICALS, INC.	Myferon 150 Forte	1996-12-01
NDC 58607-111 MARTIN EKWEALOR PHARMACEUTICALS, INC.	Myferon 150	1996-12-01